Status:
RECRUITING
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Lead Sponsor:
Chungnam National University Hospital
Collaborating Sponsors:
Chungnam National University
Conditions:
Autoimmune Hepatitis
Primary Sclerosing Cholangitis
Eligibility:
All Genders
19+ years
Brief Summary
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Detailed Description
1. The investigators will recruit study participants aged 19 and older who have been diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic ste...
Eligibility Criteria
Inclusion
- Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital.
- Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital.
- B. Exclusion
Exclusion
- Individuals under the age of 19.
- Patients or guardians who do not consent to participate in the study
Key Trial Info
Start Date :
July 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 8 2029
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06519162
Start Date
July 8 2024
End Date
July 8 2029
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chungnam National University Hospita
Daejeon, Jung-gu, South Korea, 35015